Commentary

Article

State of the Science Summit - Leukemia/Lymphoma: Chaired by Deborah Stephens, DO

State of the Science Summit - Leukemia/Lymphoma: Chaired by Deborah Stephens, DO

State of the Science Summit - Leukemia/Lymphoma: Chaired by Deborah Stephens, DO

Speakers

  • Natalie Grover, MD | University of North Carolina, Lineberger Comprehensive Cancer Center
  • Joshua Zeidner, MD | University of North Carolina, Lineberger Comprehensive Cancer Center
  • Brandi Reeves, MD | University of North Carolina, Lineberger Comprehensive Cancer Center
  • Christopher Dittus, DO, MPH | University of North Carolina, Lineberger Comprehensive Cancer Center

Topics

  • Current Standards and Future Directions in CLL
  • Sequencing Standards in MCL
  • New Approvals for AML
  • Current Standards in Myelofibrosis
  • Future Directions in Myelofibrosis
  • Bispecific Antibodies in DLBCL
Related Videos
Justin M. Watts, MD
Mazyar Shadman, MD, MPH
Craig Eckfeldt, MD, PhD, assistant professor, medicine, faculty, Microbiology, Immunology, and Cancer Biology PhD Graduate Program, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Hannah Choe, MD, an expert on GVHD
Hannah Choe, MD, an expert on GVHD
Grzegorz S. Nowakowski, MD
Combination of Zanubrutinib + Venetoclax for Treatment-naive CLL/SLL With del(17p) and/or TP53: Preliminary Results From SEQUOIA Arm D
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients With Relapsed or Refractory CLL/SLL: Results From the Phase 1 BGB-16673-101 Study